Editorial Board

Dr. Veerendra Koppolu, MSc PhD CCy

Dr. Veerendra Koppolu, MSc PhD CCy
Scientist II
Biopharmaceutical Development

Biography :

Veerendra Koppolu M.Sc Ph.D C.Cy is a senior scientist in the Department of Biologics Development at AstraZeneca/Medimmune in Gaithersburg, Maryland, USA. Dr. Koppolu is also a honorary faculty member at non-profit organization Novel Global Community Education Foundation (NGCEF) focused in guiding doctoral students. His lectures are highly valued and was awarded Robert H Emmer award and Michael S Gaines awards for this teaching. Dr. Koppolu has published over 50 peer-reviewed papers including research article, review articles, abstracts, book chapters, and books. Dr. Koppolu is serving as reviewer of 30 peer-reviewed international journals including Biotechnology Journal, Journal of Bacteriology, Future microbiology etc. Dr. Koppolu is Editorial advisory board member of International Journal of Applied and Natural Sciences, Editor of Oncology Reports and Reviews, Editor of Holistic Approaches in Oncotherapy, Editor of Open Access Journal of Surgery, Associate Editor of Cancer Therapy and Oncology International Journal, Associate Editor of Research Reviews on healthcare. Dr. Koppolu is a member in international scientific communities such as ÔÇťAmerican chemical society, American Society of Microbiology, American Association of cancer research, American Society of clinical oncology, and Internationally certified flow cytometry Association. His primary research interests include pre-clinical and clinical development of immunotherapeutic drugs including monoclonal antibodies, bispecifics, and antibody drug conjugates. At AstraZeneca, he helped in the development of drug Durvalumab, an FDA approved drug that prevents tumor immune suppression in urinary bladder cancer. He also worked in the development of immunotherapeutic vaccines for triple negative breast cancer. Dr. Koppolu holds a BS and M.Sc (Biotech) from India, PhD from University of Kansas (USA), and a certification in Flow Cytometry (C.Cy)

Research Interest :

Pre-clinical and clinical development of monoclonal antibodies and novel small molecules as breakthrough therapies for cancer and infectious diseases. Characterization and Potency evaluation of drugs and vaccines.